Live Stock Performance

About the Company

Neimeth International Pharmaceuticals PLC, established in 1997, is a leading pharmaceutical company in Nigeria, specializing in the manufacturing and marketing of a wide range of human and veterinary pharmaceuticals. The company’s product portfolio includes ethical products, over-the-counter (OTC) medications, and animal health products, serving both local and international markets.

Leadership Team

• Valentine C. Okelu – Managing Director/CEO
• Florence I. Onyenekwe – Executive Director, Finance
• Roseline A. Oputa – Director, Administration

Corporate Social Responsibility (CSR)

Neimeth International Pharmaceuticals PLC is committed to corporate social responsibility through initiatives that promote healthcare development, community engagement, and environmental sustainability. The company emphasizes responsible business practices and social impact, aiming to improve the quality of life in its host communities.

Company Milestones

• 1997: Established through a management buyout of Pfizer’s Nigerian operations.
• 2002: Listed on the Nigerian Stock Exchange.
• 2010: Launched Ciklavit, an herbal remedy for sickle cell crisis management.
• 2024: Continued expansion of product lines and market reach, maintaining a significant presence in Nigeria’s pharmaceutical industry.